See the notice on TED website
1. Buyer
1.1.
Buyer
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
2. Procedure
2.1.
Procedure
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Description: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Procedure identifier: eead91cd-644f-49f1-9dc1-1443539a5b83
Internal identifier: 2021/02385
2.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
2.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
2.1.4.
General information
Legal basis:
Directive 2014/24/EU
5. Lot
5.1.
Lot: LOT-0001
Title: 1 - INTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Description: INTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Internal identifier: 1 - INTERFERON BETA-1B (DOE) (BETAFERON®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0002
Title: 2 - INTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Description: INTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
Internal identifier: 2 - INTERFERON BETA-1B (DOE) (EXTAVIA®) PARA LA CONTINUACIÓN DE LOS TRATAMIENTOS ACTUALES
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0003
Title: 3 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
Description: LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
Internal identifier: 3 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN CURVO Y FLEXIBLE Y CON MANGO CON DESLIZADOR
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0004
Title: 4 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
Description: LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
Internal identifier: 4 - LEVONORGESTREL (DOE) SISTEMA DE LIBERACIÓN INTRAUTERINO (SLI) DE 52 MG, CON TUBO DE INSERCIÓN RECTO Y FLEXIBLE Y SIN MANGO CON DESLIZADOR
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0005
Title: 5 - TADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
Description: TADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
Internal identifier: 5 - TADALAFILO (DOE) PARA HIPERTENSIÓN ARTERIAL PULMONAR
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0006
Title: 6 - EFAVIRENZ (DOE)
Description: EFAVIRENZ (DOE)
Internal identifier: 6 - EFAVIRENZ (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0007
Title: 7 - VALGANCICLOVIR (DOE) SOLUCIÓN ORAL
Description: VALGANCICLOVIR (DOE) SOLUCIÓN ORAL
Internal identifier: 7 - VALGANCICLOVIR (DOE) SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0008
Title: 8 - BUSULFANO (DOE)
Description: BUSULFANO (DOE)
Internal identifier: 8 - BUSULFANO (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0009
Title: 9 - BORTEZOMIB (DOE)
Description: BORTEZOMIB (DOE)
Internal identifier: 9 - BORTEZOMIB (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0010
Title: 10 - METADONA (DOE) SOLUCIÓN ORAL
Description: METADONA (DOE) SOLUCIÓN ORAL
Internal identifier: 10 - METADONA (DOE) SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0011
Title: 11 - METADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
Description: METADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
Internal identifier: 11 - METADONA (DOE) CONCENTRADO PARA SOLUCIÓN ORAL
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
5.1.
Lot: LOT-0012
Title: 12 - FIBRINÓGENO HUMANO (DOE)
Description: FIBRINÓGENO HUMANO (DOE)
Internal identifier: 12 - FIBRINÓGENO HUMANO (DOE)
5.1.1.
Purpose
Main nature of the contract: Supplies
Main classification (cpv): 33600000 Pharmaceutical products
5.1.2.
Place of performance
Country subdivision (NUTS): Araba/Álava (ES211)
5.1.3.
Estimated duration
Duration: 1 Year
5.1.4.
Renewal
Maximum renewals: 0
5.1.6.
General information
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA): yes
5.1.12.
Terms of procurement
Terms of contract:
The execution of the contract must be performed within the framework of sheltered employment programmes: No
Electronic invoicing: Required
Electronic ordering will be used: no
Electronic payment will be used: no
5.1.16.
Further information, mediation and review
Review organisation: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Information about review deadlines: Se iniciará mediante escrito que deberá presentarse en el plazo de 15 días hábiles. Dicho plazo se computará conforme a la Ley de Contratos del Sector Público.
Organisation providing additional information about the procurement procedure: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
6. Results
Value of all contracts awarded in this notice: 1 804 832,00 EUR
6.1.
Result lot identifier: LOT-0001
6.1.2.
Information about winners
Winner:
Official name: BAYER HISPANIA S L
Tender:
Tender identifier: 1189440
Identifier of lot or group of lots: LOT-0001
Value of the tender: 340 000,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00001
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0003
6.1.2.
Information about winners
Winner:
Official name: BAYER HISPANIA S L
Tender:
Tender identifier: 1189441
Identifier of lot or group of lots: LOT-0003
Value of the tender: 166 972,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00002
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0004
6.1.2.
Information about winners
Winner:
Official name: GEDEONRICHTERIBERICA SAU
Tender:
Tender identifier: 1189442
Identifier of lot or group of lots: LOT-0004
Value of the tender: 179 920,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00003
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0005
6.1.2.
Information about winners
Winner:
Official name: ACCORD HEALTHCARE, S.L.U.
Tender:
Tender identifier: 1189443
Identifier of lot or group of lots: LOT-0005
Value of the tender: 11 550,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00004
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0008
6.1.2.
Information about winners
Winner:
Official name: FRESENIUS KABI
Tender:
Tender identifier: 1189444
Identifier of lot or group of lots: LOT-0008
Value of the tender: 55 200,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00005
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0009
6.1.2.
Information about winners
Winner:
Official name: FRESENIUS KABI
Tender:
Tender identifier: 1189445
Identifier of lot or group of lots: LOT-0009
Value of the tender: 37 590,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00006
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
6.1.
Result lot identifier: LOT-0012
6.1.2.
Information about winners
Winner:
Official name: OCTAPHARMA, S.A.
Tender:
Tender identifier: 1189446
Identifier of lot or group of lots: LOT-0012
Value of the tender: 1 013 600,00 EUR
Contract information:
Identifier of the contract: 2021/02385252_00007
Title: Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)
Date of the conclusion of the contract: 29/08/2022
7. Modification
7.1.
Modification
Identifier of the previous contract award notice: 524369-2024
Reason for modification: Need for modifications because of circumstances which a diligent buyer could not predict.
Description: Incidencias contractuales 1: Fecha resolución: 2025-03-11+01:00. Importe: 0.
7.1.1.
Change
Description of modifications: Incidencias contractuales
Section identifier: CON-0007
8. Organisations
8.1.
ORG-0001
Official name: Órgano Administrativo de Recursos Contractuales de la Comunidad Autónoma de Euskadi
Registration number: 66221.0
Postal address: C/ Donostia-San Sebastián, 1
Town: Vitoria-Gasteiz
Postcode: 01010
Country: Spain
Telephone: +34 945018000
Roles of this organisation:
Review organisation
8.1.
ORG-0003
Official name: OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Registration number: S5100023J
Postal address: Alava, 45
Town: Vitoria-Gasteiz
Postcode: 01006
Country: Spain
Contact point: Servicio de Farmacia
Telephone: +34 945006018
Roles of this organisation:
Buyer
Organisation providing additional information about the procurement procedure
8.1.
ORG-0005
Official name: BAYER HISPANIA S L
Registration number: B08193013
Postal address: Avenida baix Llobregat, 3 -5
Town: Sant Joan Despí
Postcode: 08970
Country: Spain
Telephone: +34 934956774
Fax: +34 934956502
Roles of this organisation:
Tenderer
Winner of these lots: LOT-0001, LOT-0003
8.1.
ORG-0007
Official name: GEDEONRICHTERIBERICA SAU
Registration number: A28679868
Postal address: PEDRO I PONS Nº 9
Town: Barcelona
Postcode: 08034
Country: Spain
Telephone: +34 691815443
Roles of this organisation:
Tenderer
Winner of these lots: LOT-0004
8.1.
ORG-0008
Official name: ACCORD HEALTHCARE, S.L.U.
Registration number: B65112930
Postal address: 08039
Town: Barcelona
Postcode: 08039
Country: Spain
Telephone: +34 933010064
Roles of this organisation:
Tenderer
Winner of these lots: LOT-0005
8.1.
ORG-0009
Official name: FRESENIUS KABI
Registration number: A08130502
Postal address: Marina 16-18
Town: Barcelona
Postcode: 08005
Country: Spain
Telephone: +34 932256565
Roles of this organisation:
Tenderer
Winner of these lots: LOT-0008, LOT-0009
8.1.
ORG-0011
Official name: OCTAPHARMA, S.A.
Registration number: A79198339
Postal address: Avda. Castilla, 2
Town: San Fernando de Henares
Postcode: 28830
Country: Spain
Telephone: +34 916487298
Roles of this organisation:
Tenderer
Winner of these lots: LOT-0012
Notice information
Notice identifier/version: 5a575e95-9268-45e9-856d-3a4129025199 - 03
Form type: Contract modification
Notice type: Contract modification notice
Notice subtype: 38
Notice dispatch date: 13/03/2025 16:00:04 (UTC+01:00) Central European Time, Western European Summer Time
Languages in which this notice is officially available: Spanish
Notice publication number: 170895-2025
OJ S issue number: 53/2025
Publication date: 17/03/2025